Substance abuse

There is substantial clinical need to recognize the individuals who need care for cognitive issues that go beyond normal aging. These problems are noticeable, but clinicians have lacked a reliable diagnosis by which to assess symptoms the most proper treatment or services. Recent studies suggest that identifying mild neurocognitive disorders in the early stages itself may allow interventions to be more effective. Early intervention efforts may enable the use of treatments that are ineffective at more severe levels of impairment and may prevent or slow progression. Researchers will analyze how well the new diagnostic criteria address the depressive symptoms, as well as potential therapies like educational or brain stimulation.

  • lung cancer 
  • emphysema
  • Heart stroke

Related Conference of Substance abuse

April 24-25, 2017

16th World Congress on Psychiatry and Psychological Syndromes

Las Vegas, Nevada, USA
May 15-16, 2017

18th International Congress on Applied Psychology and Psychiatry

Munich, Germany@ Novotel München City Arnulfpark
June 21-23, 2017

3rd International Conference on Mental Health and Human Resilience

@ Holiday Inn London, Brentford Lock, UK
July 12-13, 2017

19th Global Congress on Pediatricians & Child Psychiatry

Chicago, Illinios, USA
October 16-17, 2017

2nd Global Clinical Psychologists Annual Meeting

Osaka, Japan
October 19-20, 2017

25th World Summit on Psychology, Psychiatry & Psychotherapy

San Francisco, California, USA
November 02-03, 2017

27th World Congress on Clinical Psychiatry

Atlanta, USA
November 20-21, 2017

28th International Conference on Psychiatry & Mental Health

Melbourne, Australia

Substance abuse Conference Speakers

Recommended Sessions

Related Journals

Are you interested in